Omnicell Shares Rally Premarket After Swing to 1Q Profit

Dow Jones

Apr 28

By Rob Curran

Shares of Omnicell rose sharply after the provider of healthcare technology swung to a first-quarter profit on better-than-anticipated revenue growth.

The Fort Worth, Texas, provider of medicine-dispensing equipment and other automated healthcare technology posted earnings of $11.4 million, or 25 cents a share, in contrast to a loss of $7.02 million, or 15 cents a share, a year earlier.

Analysts were looking for income of zero cents per share, as per FactSet.

Revenue rose 15% to $309.9 million, topping the mean analyst estimate of $304 million.

For the second quarter, Omnicell targeted adjusted earnings of 40 cents to 48 cents a share on revenue in a range between $307 million and $313 million. For 2026, the company projected adjusted earnings of $1.80 to $2 a share on revenue between about $1.22 billion and $1.26 billion.

Shares of Omnicell rose 21% to $45.50, premarket.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

April 28, 2026 09:04 ET (13:04 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2630307918"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2630307918\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2630307918?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 21:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2630307918","market":"other","top_or_hot":-1,"title":"Omnicell Shares Rally Premarket After Swing to 1Q Profit","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Rob Curran \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> rose sharply after the provider of healthcare technology swung to a first-quarter profit on better-than-anticipated revenue growth. \n</p>\n<p>\n  The Fort Worth, Texas, provider of medicine-dispensing equipment and other automated healthcare technology posted earnings of $11.4 million, or 25 cents a share, in contrast to a loss of $7.02 million, or 15 cents a share, a year earlier. \n</p>\n<p>\n  Analysts were looking for income of zero cents per share, as per FactSet. \n</p>\n<p>\n  Revenue rose 15% to $309.9 million, topping the mean analyst estimate of $304 million. \n</p>\n<p>\n  For the second quarter, Omnicell targeted adjusted earnings of 40 cents to 48 cents a share on revenue in a range between $307 million and $313 million. For 2026, the company projected adjusted earnings of $1.80 to $2 a share on revenue between about $1.22 billion and $1.26 billion. \n</p>\n<p>\n  Shares of Omnicell rose 21% to $45.50, premarket. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 28, 2026 09:04 ET (13:04 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omnicell Shares Rally Premarket After Swing to 1Q Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmnicell Shares Rally Premarket After Swing to 1Q Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-04-28 21:04</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Rob Curran \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> rose sharply after the provider of healthcare technology swung to a first-quarter profit on better-than-anticipated revenue growth. \n</p>\n<p>\n  The Fort Worth, Texas, provider of medicine-dispensing equipment and other automated healthcare technology posted earnings of $11.4 million, or 25 cents a share, in contrast to a loss of $7.02 million, or 15 cents a share, a year earlier. \n</p>\n<p>\n  Analysts were looking for income of zero cents per share, as per FactSet. \n</p>\n<p>\n  Revenue rose 15% to $309.9 million, topping the mean analyst estimate of $304 million. \n</p>\n<p>\n  For the second quarter, Omnicell targeted adjusted earnings of 40 cents to 48 cents a share on revenue in a range between $307 million and $313 million. For 2026, the company projected adjusted earnings of $1.80 to $2 a share on revenue between about $1.22 billion and $1.26 billion. \n</p>\n<p>\n  Shares of Omnicell rose 21% to $45.50, premarket. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 28, 2026 09:04 ET (13:04 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2630307918","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2630307918","pubTimestamp":1777381440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Omnicell rose sharply after the provider of healthcare technology swung to a first-quarter profit on better-than-anticipated revenue growth.The Fort Worth, Texas, provider of medicine-dispensing equipment and other automated healthcare technology posted earnings of $11.4 million, or 25 cents a share, in contrast to a loss of $7.02 million, or 15 cents a share, a year earlier.Analysts were looking for income of zero cents per share, as per FactSet.Revenue rose 15% to $309.9 million, topping the mean analyst estimate of $304 million.For the second quarter, Omnicell targeted adjusted earnings of 40 cents to 48 cents a share on revenue in a range between $307 million and $313 million. For 2026, the company projected adjusted earnings of $1.80 to $2 a share on revenue between about $1.22 billion and $1.26 billion.Shares of Omnicell rose 21% to $45.50, premarket.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","OMCL":"Omnicell","BK4167":"医疗保健技术"},"translate_title":"Omnicell股价在第一季度盈利后盘前上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":1.5},"content_text":"By Rob Curran \n\n\n \n\n\n  Shares of Omnicell rose sharply after the provider of healthcare technology swung to a first-quarter profit on better-than-anticipated revenue growth. \n\n\n  The Fort Worth, Texas, provider of medicine-dispensing equipment and other automated healthcare technology posted earnings of $11.4 million, or 25 cents a share, in contrast to a loss of $7.02 million, or 15 cents a share, a year earlier. \n\n\n  Analysts were looking for income of zero cents per share, as per FactSet. \n\n\n  Revenue rose 15% to $309.9 million, topping the mean analyst estimate of $304 million. \n\n\n  For the second quarter, Omnicell targeted adjusted earnings of 40 cents to 48 cents a share on revenue in a range between $307 million and $313 million. For 2026, the company projected adjusted earnings of $1.80 to $2 a share on revenue between about $1.22 billion and $1.26 billion. \n\n\n  Shares of Omnicell rose 21% to $45.50, premarket. \n\n\n \n\n\n  Write to Rob Curran at rob.curran@dowjones.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2026 09:04 ET (13:04 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}